Skip to main content
H.R. 3109 116th Congress House

GEDI Act

Official title: To provide grants to better understand and reduce gestational diabetes, and for other purposes.

Introduced: June 5, 2019 See on congress.gov
Health Advisory bodiesDigestive and metabolic diseasesHealth information and medical recordsHealth programs administration and funding
More subjectsShow fewer subjects
Health promotion and preventive careMedical researchMedical tests and diagnostic methodsSex and reproductive healthWomen's health
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 6, 2019
Referred to the Subcommittee on Health.
Jun 5, 2019
Referred to the House Committee on Energy and Commerce.
Jun 5, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 6, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Gestational Diabetes Act of 2019 or the GEDI Act

This bill amends the Public Health Service Act to direct the Centers for Disease Control and Prevention (CDC) to develop a multisite gestational diabetes (i.e., diabetes occuring during pregnancy) research project to expand and enhance surveillance data and public health research about gestational diabetes. 

The CDC must: (1) award grants for demonstration projects to reduce the incidence of gestational diabetes, the recurrence of such disease in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes; and (2) work with state and tribal diabetes prevention and control programs assisted by the CDC to encourage postpartum follow-up after gestational diabetes to reduce the incidence of gestational diabetes and its recurrence, the development of type 2 diabetes in at-risk women, and related complications.

 Related & companion bills 3
  • HR 5423 Reintroduction of GEDI Act
  • S 4819 Health Equity and Accountability Act of 2020
  • HR 6637 Health Equity and Accountability Act of 2020
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3109: GEDI Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-3109/
MLA
"H.R. 3109: GEDI Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-3109/.
Bluebook (legal)
H.R. 3109, 116th Cong. (2026), https://openamerica.io/bill/116-HR-3109/.
Markdown link
[H.R. 3109: GEDI Act](https://openamerica.io/bill/116-HR-3109/)
Report a problem